AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 101 filers reported holding AVROBIO INC in Q1 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 80 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 80 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 80 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 80 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 80 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 80 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 80 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -66.7% | 80 | -61.0% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 205 | +14.5% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 179 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | +33.3% | 179 | -11.4% | 0.00% | – |
| Q3 2019 | $3,000 | +50.0% | 202 | +32.9% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 152 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -25.0% | 152 | -39.2% | 0.00% | – |
| Q4 2018 | $4,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,236,123 | $21,570,000 | 14.96% |
| Aisling Capital Management LP | 1,009,779 | $17,621,000 | 6.72% |
| Burrage Capital Management LLC | 225,900 | $3,942,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $5,506,000 | 1.58% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $13,960,000 | 1.36% |
| Camber Capital Management LP | 1,350,000 | $23,558,000 | 1.35% |
| Parkman Healthcare Partners LLC | 190,593 | $3,326,000 | 0.94% |
| Eventide Asset Management | 1,905,307 | $33,248,000 | 0.72% |
| Penn Mutual Asset Management | 37,306 | $651,000 | 0.66% |
| EMERALD ADVISERS, LLC | 832,474 | $14,527,000 | 0.63% |